Company
Company where Dr Baker was a non-executive director between 2021 and 2024
Every investor coverage indicates participated in a round Radiopharm Theranostics raised.
Companies Radiopharm Theranostics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Radiopharm Theranostics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Percheron Therapeutics has appointed Arovella Therapeutics' former leader Michael Baker as CEO from October, with James Garner departing for an overseas role while joining the board as a non-executive director.
Techboard's monthly roundup tallies October 2022 startup funding at $661m across 99 deals, listing megadeals such as Airwallex, acquisitions, Square Peg's $861m fund close and government grants to program operators.
Also @AuManufacturing
AFR healthcare and fitness section roundup: Early Bird raised $2 million led by Hyper Ventures; Resmed sold MatrixCare; Radiopharm seeks $16 million; plus Mayne Pharma, Healthscope, Sigma and policy stories.
Also SmartCompany